Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

World FinTech Report 2019: The Industry is Transitioning from Open Banking to “Open X”

Published

on

Reading Time: 5 minutes

Driven by four fundamental market shifts, the industry is moving
to a shared marketplace that demands improved collaboration and
specialization

PARIS–(BUSINESS WIRE)–The World
FinTech Report (WFTR) 2019
, published today by Capgemini
and
Efma,
indicates that even though Open Banking has yet to reach maturity, the
financial services industry is entering a new phase of innovation –
referred to as “Open X” – that will require deeper collaboration
and specialization. The report advocates that banks and other financial
services ecosystem players must begin to plan accordingly and evolve
their business models.

The WFTR 2019 identifies a dual challenge: FinTechs are
struggling to scale their operations and banks are stalling on FinTech
collaboration. As a result, industry players are looking to leapfrog
beyond Open Banking towards Open X, which is a more effective,
structured form of collaboration, facilitated by Application Program
Interface (API)1 standardization and shared insights from
customer data. The era of Open X will create an integrated marketplace,
with specialized roles for each player that will enable a seamless
exchange of data and services, improving customer experience, and
expediting product innovation.

Key findings of the report include:

Open X will transform industry norms and assumptions

The advent of Open X is being driven by four fundamental shifts:

  • A move away from a focus on products to an emphasis on customer
    experience
  • The evolution of data as the critical asset
  • A shift from prioritizing ownership to facilitating shared access
  • Emphasis on partnering to innovate instead of buying or building new
    solutions

Open X will lead the financial services industry to a shared ecosystem
or marketplace, in which the industry reintroduces the re-bundling of
products and services, and both banks and FinTechs must re-evaluate
their strategy for innovation and serving customers.

APIs will be critical Open X enablers

APIs, which allow third parties to access bank systems and data in a
controlled environment, will be catalysts to creating the Open X
marketplace. While customer data is already widely shared and leveraged
in the industry, standardized APIs are not commonplace. Although
requirements and regulations are complex, standardization will help to
reduce fraud, improve interoperability, increase speed to market, and
enhance scalability.

The WFTR 2019 also finds that industry players are looking at two
potential monetization models for APIs – revenue-sharing (which 60% of
banks and 70% of FinTechs think is feasible) and API access fees
(supported by 46% of banks and 55% of FinTechs). However, only about a
third of banking executives said they are currently well equipped to
monetize APIs.

Privacy, security and collaboration concerns may slow progress

While banks and FinTechs said they understand the importance of
collaboration, apprehension over privacy and security remain top of
mind. When asked what concerns them about Open Banking, the vast
majority of banks identified data security (76%), customer privacy
(76%), and loss of control of customer data (63%). FinTechs were more
optimistic about Open Banking, but 50% expressed fears over security and
privacy, and 38% over the loss of control of customer data.

When asked about roadblocks to effective collaboration, 66% of banks and
70% of FinTechs pointed to a difference in the other’s organizational
culture/mind-set, 52% of banks and 70% of FinTechs mentioned process
barriers, and a lack of long-term vision and objectives were listed as
gates by 54% of banks and 60% of FinTechs. Only 26% of bank executives
and 43% of FinTech leaders said they had identified the right Open
Banking collaboration partner. These responses suggest that many banks
and FinTechs remain unprepared for Open Banking, let alone for the
increased demands of data sharing and integration that Open X will bring.

Open X participants must choose strategic, specialty-based roles

Within the Open X marketplace, banks will need to enhance their
integrated (traditional) model first and then focus on areas of
specialized strength. The WFTR 2019 identifies three strategic roles
expected to evolve as a part of Open X:

  • Suppliers will develop products and services;
  • Aggregators will amass products and services from the
    marketplace and distribute them through internal channels, holding
    onto customer relationships;
  • Orchestrators will act as market connectors and coordinators,
    facilitating partner interactions.

According to the report, integrated firms2 are likely to
struggle to match the time to market of an ecosystem of specialists and
find it challenging to meet the unique demands from customers. Within
the Open X marketplace, many incumbents may not be best positioned to
compete as an Orchestrator and their strengths may lead them to other
roles. No matter what role they assume in Open X, however, they must
recruit the right talent, leverage data and technology, and collaborate
with FinTechs to first ensure better internal capabilities for
competitive delivery of relevant services in the current Open Banking
scenario.

“Open Banking has long been regarded as transformational for
financial services, but this report shows it is just one part of a much
bigger picture,”
said Anirban Bose, CEO of Capgemini’s Financial
Services and Member of the Group Executive Board. “The industry is on
the verge of a more comprehensive evolution, where there is opportunity
to leapfrog into an integrated marketplace that we are calling Open X.

In Open X, there will be seamless sharing of data, and ecosystem
partners will be able to collaborate in a far more comprehensive way.
Our research suggests that banks and FinTechs need to prepare themselves
for a more radical change than many previously anticipated.”

“The findings of the report could not be clearer: collaboration will
be the foundation of the future of financial services,”
said Vincent
Bastid, Secretary General of Efma. “In the era of Open X, ecosystem
players will have to work together more effectively than they have
previously. Only by embracing collaboration and new, specialist roles
can both banks and FinTechs thrive and best serve their customers. It’s
clear that many barriers to collaboration still exist, and there is an
urgent need to overcome them for collective benefit.”

Report methodology

The World FinTech Report 2019 is based on a global survey
encompassing responses from 116 traditional financial services firms and
40 FinTech firms including banking and lending, payments and transfers,
and investment management. Questions sought to yield perspectives from
both FinTech and traditional financial services firms— exploring the
emergence of Open Banking in the financial services industry. It sheds
light on the impact the new ecosystem will have on all the stakeholders,
the challenges and concerns that firms will face, and the emergence of
new businesses and monetization models in this space.

About Capgemini

A global leader in consulting, technology services and digital
transformation, Capgemini is at the forefront of innovation to address
the entire breadth of clients’ opportunities in the evolving world of
cloud, digital and platforms. Building on its strong 50-year heritage
and deep industry-specific expertise, Capgemini enables organizations to
realize their business ambitions through an array of services from
strategy to operations. Capgemini is driven by the conviction that the
business value of technology comes from and through people. It is a
multicultural company of over 200,000 team members in more than 40
countries. The Group reported 2018 global revenues of EUR 13.2 billion.

Visit us at www.capgemini.com.
People matter, results count

About Efma

A global non-profit organization, established in 1971 by banks and
insurance companies, Efma facilitates networking between
decision-makers. It provides quality insights to help banks and
insurance companies make the right decisions to foster innovation and
drive their transformation. Over 3,300 brands in 130 countries are Efma
members.

Headquarters in Paris. Offices in London, Brussels, Andorra, Stockholm,
Bratislava, Dubai, Milan, Montreal, Istanbul, Beijing, Tokyo and
Singapore. Learn more www.efma.com.

____________________________________________
1
Application programming interface (API) refers to a set of functions and
procedures that a player opens to the external world to allow the
creation of applications that access the features or data of an
operating system, application, or other service.
2
Integrated firms refer to the firms that perform all the functions on
their own without collaborating or leveraging other firms in the
ecosystem. Many of the banks in the current ecosystem are integrated
firms as they build, produce, and distribute their own products for all
business lines (without leveraging FinTechs or other players in the
ecosystem)

Contacts

Capgemini Press Contacts:
Mary Sacchi (North America)
WE
Communications for Capgemini

Tel.: +1 (212) 551 4818
E-mail:
[email protected]

Liz Fletcher (EMEA)
WE Communications for Capgemini
Tel.:
+44 (0) 20 7632 3816

E-mail: [email protected]

Efma Press Contact:
Anna Quinn
Tel.: +33 1 47
42 6771

E-mail: [email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect

Published

on

Continue Reading

Cannabis

Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand

Published

on

Continue Reading

transfer

IMC to transfer its Oranim Pharmacy shares back to the seller

Published

on

imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller

TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the  seller.

“With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential,” said Oren Shuster, CEO of IMC. “With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment.”

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC’s products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.

Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to,  the occurrence of growth opportunities and the likelihood of growth potential.

Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the development and introduction of new products; continuing demand for medical and adult-use recreational cannabis in the markets in which the Company operates; the Company’s ability to reach patients through both e-commerce and brick and mortar retail operations; the Company’s ability to maintain and renew or obtain required licenses; the effectiveness of its products for medical cannabis patients and recreational consumers; and the Company’s ability to market its brands and services successfully to its anticipated customers and medical cannabis patients.

The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward looking statements due to a number of factors and risks. These include: any failure of the Company to maintain “de facto” control over Focus Medical in accordance with IFRS 10; the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the effect of the reform on the Company; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group”) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.

The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Company Contacts:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
[email protected]

Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller-302117984.html

Continue Reading

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania